ArticleZhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi2025
[High-throughput sequencing in identifying somatic hypermutation in immunoglobulin heavy chain variable regions with complex clonal backgrounds].
M G Gao, R Wei, Y Liu, X J Huang, S M Yang, X S Zhao
Abstract readEnglish AbstractComparative Study
In one paragraphArticle in Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
6 authors.
M G GaoPeking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, 100044 Beijing, China.
R WeiPeking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, 100044 Beijing, China.
Y LiuPeking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, 100044 Beijing, China.
X J HuangPeking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, 100044 Beijing, China.
S M YangPeking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, 100044 Beijing, China.
X S ZhaoPeking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, 100044 Beijing, China.
Funding
CAMS Innovation Fund for Medical Science (CIFMS) 2019-12M-5-034Peking University People's Hospital Scientific Research Development Funds RDL2023-08
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
High-Throughput Nucleotide SequencingImmunoglobulin Heavy ChainsImmunoglobulin Variable RegionSomatic Hypermutation, ImmunoglobulinAdultAgedAged, 80 and overFemaleHumansMaleMiddle AgedRetrospective StudiesImmunoglobulin Heavy ChainsImmunoglobulin Variable RegionImmunoglobulin heavy chain variable geneNext generation sequencingSanger sequencingSomatic hypermutation
Identifiers
PMID41145284
PMCPMC12580819
What Socratic holds
Textmetadata
LicenceCC BY
Read underepoch 390